Clark Capital Management Group, Inc. - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 118 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Clark Capital Management Group, Inc. ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q4 2019$1,708,000
+23.9%
29,995
+16.4%
0.04%
+16.1%
Q3 2019$1,379,000
-13.1%
25,765
-3.0%
0.03%
-6.1%
Q2 2019$1,586,000
-31.4%
26,557
-28.4%
0.03%
-40.0%
Q1 2019$2,311,00037,0840.06%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q1 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders